In most cases, tumors with high expression of PD-1 or PD-L1 have poor prognosis, but part of them are sensitive to ICI inhibitor, the representative example is triple negative breast cancer (45). The gene discussed is PDCD1; the disease is triple-negative breast carcinoma.